Vanguard Global Advisers »

Ligand Pharmaceuticals In shares owned by Vanguard Global Advisers

Quarter-by-quarter ownership of Ligand Pharmaceuticals In (LGND) shares owned by Vanguard Global Advisers from 13F filings

Historical chart of Vanguard Global Advisers investment in Ligand Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Ligand Pharmaceuticals In held by Vanguard Global Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ligand Pharmaceuticals In by Vanguard Global Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.7M 8.3k 199.65

More positions owned by Vanguard Global Advisers

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Vanguard Specialized Funds Div App Etf (VIG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)

View all positions for Vanguard Global Advisers

Top funds holding Ligand Pharmaceuticals In

BlackRock
Vanguard Group
Vanguard Portfolio Management
Henderson Group
Vanguard Capital Management
Invesco
State Street Corporation
FMR
Nomura Asset Management International
Franklin Resources
Chicago Capital
Geode Capital Management
Massachusetts Financial Services
Congress Asset Management
Stephens Investment Management Group

View all funds holding Ligand Pharmaceuticals In